BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15920071)

  • 1. Underdiagnosis of peripheral neuropathy in type 2 diabetes.
    Herman WH; Kennedy L
    Diabetes Care; 2005 Jun; 28(6):1480-1. PubMed ID: 15920071
    [No Abstract]   [Full Text] [Related]  

  • 2. Bedside scoring procedure for the diagnosis of diabetic peripheral neuropathy in young patients with type 1 diabetes mellitus.
    Shalitin S; Josefsberg Z; Lilos P; de-Vries L; Phillip M; Weintrob N
    J Pediatr Endocrinol Metab; 2002 May; 15(5):613-20. PubMed ID: 12014520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on Tesfaye et al. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes care 2013;36:2456-2465.
    Nickerson DS
    Diabetes Care; 2014 May; 37(5):e120. PubMed ID: 24757246
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program.
    Salvotelli L; Stoico V; Perrone F; Cacciatori V; Negri C; Brangani C; Pichiri I; Targher G; Bonora E; Zoppini G
    J Diabetes Complications; 2015; 29(8):1066-70. PubMed ID: 26227575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China.
    Liu F; Bao Y; Hu R; Zhang X; Li H; Zhu D; Li Y; Yan L; Li Y; Lu J; Li Q; Zhao Z; Ji Q; Jia W
    Diabetes Metab Res Rev; 2010 Sep; 26(6):481-9. PubMed ID: 20661939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'VPTscore'--a useful predictor of neuropathy in diabetic patients.
    Coppini DV; Weng C; Young PJ; Sönksen PH
    Diabet Med; 2000 Jun; 17(6):488-90. PubMed ID: 10975223
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.
    Lehtinen JM; Uusitupa M; Siitonen O; Pyörälä K
    Diabetes; 1989 Oct; 38(10):1307-13. PubMed ID: 2551761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-g monofilament is clinically useful for detecting diabetic peripheral neuropathy.
    Nagai Y; Sugiyama Y; Abe T; Nomura G
    Diabetes Care; 2001 Jan; 24(1):183-4. PubMed ID: 11194233
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular neuropathy in peripheral neuropathies.
    Evliyaoglu F; Karadag R; Burakgazi AZ
    Muscle Nerve; 2012 Nov; 46(5):681-6. PubMed ID: 23055310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of peripheral neuropathy in youth with type 1 diabetes.
    Moser JT; Langdon DR; Finkel RS; Ratcliffe SJ; Foley LR; Andrews-Rearson ML; Murphy KM; Lipman TH
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e3-6. PubMed ID: 23391743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus.
    Pai YW; Lin CH; Lee IT; Chang MH
    Diabetes Metab Syndr; 2018; 12(2):111-116. PubMed ID: 29042249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy in young-old and old-old patients.
    Verghese J; Bieri PL; Gellido C; Schaumburg HH; Herskovitz S
    Muscle Nerve; 2001 Nov; 24(11):1476-81. PubMed ID: 11745949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions.
    Thomas PK
    Eur Neurol; 1999; 41 Suppl 1():35-43. PubMed ID: 10023127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the related risk factors of diabetic peripheral neuropathy].
    Nie C; Bao HP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):467-9. PubMed ID: 23627032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China.
    Li L; Chen J; Wang J; Cai D
    Prim Care Diabetes; 2015 Jun; 9(3):191-5. PubMed ID: 25163987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of human diabetic neuropathy.
    Malik RA
    Handb Clin Neurol; 2014; 126():249-59. PubMed ID: 25410227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea.
    Won JC; Kwon HS; Kim CH; Lee JH; Park TS; Ko KS; Cha BY
    Diabet Med; 2012 Sep; 29(9):e290-6. PubMed ID: 22519862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the clinical diagnosis of diabetic peripheral neuropathy.
    Chicharro-Luna E; Pomares-Gómez FJ; Ortega-Ávila AB; Coheña-Jiménez M; Gijon-Nogueron G
    Prim Care Diabetes; 2020 Feb; 14(1):53-60. PubMed ID: 31208891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral and autonomic neuropathy in a group of diabetic patients: clinical and neurophysiologic correlations].
    Violante F; Santagostino I; Pais M; Fontana P
    Riv Neurobiol; 1984; 30(2-3):398-402. PubMed ID: 6100524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.